Apply to

What’s New!

PMP Series - Rx pad with meds and outline of the state of maine
June 18, 2024
Prescribing Buprenorphine: What is the Role and Risk of Monoproduct in Maintenance Therapy of Opioid Use Disorder (OUD)?
Presented by Andrea Truncali, MD, MPH | Stephanie Nichols, PharmD, BCPP, MPH, FCCP

Is monoproduct (buprenorphine) truly lower risk than combination (buprenorphine-naloxone) therapy and if so, how much? What should a provider do with patients who report adverse effects of buprenorphine/naloxone?


More Information

Adolescents & Young Adults ECHO: Expanding Services for OUD/SUD, Mental Health, and Other Complexities

More Information

Xylazine and Wound Care

View the Resources

Screening, Brief Intervention, and Referral to Treatment (SBIRT) Resources

View these Resources

Maine Opioid Clinical Advisory Committee Clinical Guidance Documents

View these Documents

Maine Prescription Monitoring Program (PMP)

View these Resources